Tsuda Makoto, Toyomitsu Emika, Komatsu Takayuki, Masuda Takahiro, Kunifusa Emiko, Nasu-Tada Kaoru, Koizumi Schuichi, Yamamoto Kimiko, Ando Joji, Inoue Kazuhide
Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Glia. 2008 Apr;56(5):579-85. doi: 10.1002/glia.20641.
We have previously shown that activation of the ATP-gated ion channel subtype P2X(4) receptors (P2X(4)Rs) in the spinal cord, the expression of which is upregulated in microglia after nerve injury, is necessary for producing neuropathic pain. The upregulation of P2X(4)Rs in microglia is, therefore, a key process in neuropathic pain, but the mechanism remains unknown. Here, we find a fibronectin/integrin-dependent mechanism in the upregulation of P2X(4)Rs. Microglia cultured on dishes coated with fibronectin, an extracellular matrix molecule, expressed a higher level of P2X(4)R protein when compared with those cultured on control dishes. The increase was suppressed by echistatin, a peptide that selectively blocks beta(1) and beta(3)-containing integrins, and with a function-blocking antibody of beta(1) integrin. In in vivo studies, the upregulation of P2X(4)Rs in the spinal cord after spinal nerve injury was significantly suppressed by intrathecal administration of echistatin. Tactile allodynia in response to nerve injury and intrathecal administration of ATP- and fibronectin-stimulated microglia was inhibited by echistatin. Furthermore, intrathecal administration of fibronectin in normal rats increased the level of P2X(4)R protein in the spinal cord and produced tactile allodynia. Moreover, the fibronectin-induced allodynia was not observed in mice lacking P2X(4)R. Taken together with the results of our previous study showing an increase in the spinal fibronectin level after nerve injury, the present results suggest that the fibronectin/integrin system participates in the upregulation of P2X(4)R expression after nerve injury and subsequent neuropathic pain.
我们之前已经表明,脊髓中ATP门控离子通道亚型P2X(4)受体(P2X(4)Rs)的激活是产生神经性疼痛所必需的,该受体在神经损伤后小胶质细胞中的表达上调。因此,小胶质细胞中P2X(4)Rs的上调是神经性疼痛的关键过程,但其机制仍不清楚。在这里,我们发现了一种纤连蛋白/整合素依赖性机制参与P2X(4)Rs的上调。与在对照培养皿中培养的小胶质细胞相比,在涂有细胞外基质分子纤连蛋白的培养皿上培养的小胶质细胞表达更高水平的P2X(4)R蛋白。这种增加被echistatin(一种选择性阻断含β(1)和β(3)整合素的肽)以及β(1)整合素的功能阻断抗体所抑制。在体内研究中,鞘内注射echistatin可显著抑制脊髓神经损伤后脊髓中P2X(4)Rs的上调。echistatin可抑制对神经损伤以及鞘内注射ATP和纤连蛋白刺激的小胶质细胞产生的触觉异常性疼痛。此外,在正常大鼠中鞘内注射纤连蛋白可增加脊髓中P2X(4)R蛋白的水平并产生触觉异常性疼痛。而且,在缺乏P2X(4)R的小鼠中未观察到纤连蛋白诱导的异常性疼痛。结合我们之前的研究结果显示神经损伤后脊髓纤连蛋白水平升高,目前的结果表明纤连蛋白/整合素系统参与神经损伤后P2X(4)R表达的上调以及随后的神经性疼痛。